Literature DB >> 23617593

An interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B.

P M Rallapalli1, G Kemball-Cook, E G Tuddenham, K Gomez, S J Perkins.   

Abstract

BACKGROUND: Factor IX (FIX) is important in the coagulation cascade, being activated to FIXa on cleavage. Defects in the human F9 gene frequently lead to hemophilia B.
OBJECTIVE: To assess 1113 unique F9 mutations corresponding to 3721 patient entries in a new and up-to-date interactive web database alongside the FIXa protein structure.
METHODS: The mutations database was built using MySQL and structural analyses were based on a homology model for the human FIXa structure based on closely-related crystal structures.
RESULTS: Mutations have been found in 336 (73%) out of 461 residues in FIX. There were 812 unique point mutations, 182 deletions, 54 polymorphisms, 39 insertions and 26 others that together comprise a total of 1113 unique variants. The 64 unique mild severity mutations in the mature protein with known circulating protein phenotypes include 15 (23%) quantitative type I mutations and 41 (64%) predominantly qualitative type II mutations. Inhibitors were described in 59 reports (1.6%) corresponding to 25 unique mutations.
CONCLUSION: The interactive database provides insights into mechanisms of hemophilia B. Type II mutations are deduced to disrupt predominantly those structural regions involved with functional interactions. The interactive features of the database will assist in making judgments about patient management.
© 2013 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  bioinformatics; coagulation factor IX; database; hemophilia B; models; molecular; mutations; phenotypes

Mesh:

Substances:

Year:  2013        PMID: 23617593     DOI: 10.1111/jth.12276

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  45 in total

Review 1.  Genetic testing in bleeding disorders.

Authors:  C de Brasi; O El-Maarri; D J Perry; J Oldenburg; B Pezeshkpoor; A Goodeve
Journal:  Haemophilia       Date:  2014-05       Impact factor: 4.287

2.  Prophylaxis use among males with haemophilia B in the United States.

Authors:  M Ullman; Q C Zhang; S D Grosse; M Recht; J M Soucie
Journal:  Haemophilia       Date:  2017-08-06       Impact factor: 4.287

3.  Noninvasive detection of F8 int22h-related inversions and sequence variants in maternal plasma of hemophilia carriers.

Authors:  Irena Hudecova; Peiyong Jiang; Joanna Davies; Y M Dennis Lo; Rezan A Kadir; Rossa W K Chiu
Journal:  Blood       Date:  2017-05-10       Impact factor: 22.113

4.  CRISPR/Cas9-mediated somatic and germline gene correction to restore hemostasis in hemophilia B mice.

Authors:  Cong Huai; Chenqiang Jia; Ruilin Sun; Peipei Xu; Taishan Min; Qihan Wang; Chengde Zheng; Hongyan Chen; Daru Lu
Journal:  Hum Genet       Date:  2017-05-15       Impact factor: 4.132

5.  Circumventing furin enhances factor VIII biological activity and ameliorates bleeding phenotypes in hemophilia models.

Authors:  Joshua I Siner; Benjamin J Samelson-Jones; Julie M Crudele; Robert A French; Benjamin J Lee; Shanzhen Zhou; Elizabeth Merricks; Robin Raymer; Timothy C Nichols; Rodney M Camire; Valder R Arruda
Journal:  JCI Insight       Date:  2016-10-06

6.  Mutation Spectrum and Genotype-Phenotype Analyses in a Pakistani Cohort With Hemophilia B.

Authors:  Muhammad Tariq Masood Khan; Arshi Naz; Jawad Ahmed; Tahir Shamsi; Shariq Ahmed; Nisar Ahmed; Ayisha Imran; Nazish Farooq; Muhammad Tariq Hamayun Khan; Abid Sohail Taj
Journal:  Clin Appl Thromb Hemost       Date:  2017-07-28       Impact factor: 2.389

7.  High resolution melting for F9 gene mutation analysis in patients with haemophilia B.

Authors:  Roberta Salviato; Donata Belvini; Paolo Radossi; Giuseppe Tagariello
Journal:  Blood Transfus       Date:  2018-02-28       Impact factor: 3.443

Review 8.  Using Genome Sequence to Enable the Design of Medicines and Chemical Probes.

Authors:  Alicia J Angelbello; Jonathan L Chen; Jessica L Childs-Disney; Peiyuan Zhang; Zi-Fu Wang; Matthew D Disney
Journal:  Chem Rev       Date:  2018-01-11       Impact factor: 60.622

9.  Expression and Characterization of Gly-317 Variants of Factor IX Causing Variable Bleeding in Hemophilia B Patients.

Authors:  Qiuya Lu; Likui Yang; Chandrashekhara Manithody; Xuefeng Wang; Alireza R Rezaie
Journal:  Biochemistry       Date:  2015-06-10       Impact factor: 3.162

10.  First case report of hemophilia B Leyden in Japan.

Authors:  Atsuki Yamashita; Chiai Nagae; Mika Mori; Tomoko Ashikaga; Tetsuhito Kojima; Masashi Taki
Journal:  Int J Hematol       Date:  2017-02-07       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.